Different pathogenic mechanisms have been suggested as contributing to the higher incidence of sleep breathing disorders among patients with type 2 diabetes: insulin resistance, leptin resistance, systemic inflammation and autonomic or peripheral neuropathy [1,22]. The gene discussed is LEP; the disease is peripheral neuropathy.